DOCSLIB.ORG

Automation List – 1St December 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Automation List – 1St December 2011 st Automation List – 1 December 2011 Abidec Drops Packsize 25 Adcal D3 Chewable Tabs Packsize 56 Abilify Tabs 10 Mg Packsize 28 Adcal D3 Chewable Tabs Packsize 56 Abstral Tabs 100 Micrograms Packsize 10 Adcal D3 Dissolve Effervescent Tabs Packsize 56 Abstral Tabs 100 Micrograms Packsize 30 Adcal D3 Tabs Packsize 112 Abstral Tabs 200 Micrograms Packsize 10 Adefovir Dipivoxil Tabs 10 Mg Packsize 30 Abstral Tabs 200 Micrograms Packsize 30 Adenuric Tabs 80 Mg Packsize 28 Abstral Tabs 300 Micrograms Packsize 10 Adipine 10 Mr 10 Mg Tabs Packsize 56 Abstral Tabs 300 Micrograms Packsize 30 Adipine 20 Mr 20 Mg Tabs Packsize 56 Abstral Tabs 400 Micrograms Packsize 10 Adipine 30 Xl Tabs 30 Mg Packsize 28 Abstral Tabs 400 Micrograms Packsize 30 Adipine 60 Xl Tabs 60 Mg Packsize 28 Abstral Tabs 600 Micrograms Packsize 30 Adizem Sr 120 Mg Caps Packsize 56 Acamprosate Calcium 333 Mg Ec Tabs Packsize 168 Adizem Sr 180 Mg Caps Packsize 56 Acarbose Tabs 100 Mg Packsize 90 Adizem Sr 90 Mg Caps Packsize 56 Acarbose Tabs 50 Mg Packsize 90 Adizem Sr Tabs 120 Mg Packsize 56 Accolate Tabs 20 Mg Packsize 56 Adizem Xl 120 Mg Caps Packsize 28 Accupro Tabs 10 Mg Packsize 28 Adizem Xl 180 Mg Caps Packsize 28 Accupro Tabs 20 Mg Packsize 28 Adizem Xl 200 Mg Caps Packsize 28 Accupro Tabs 40 Mg Packsize 28 Adizem Xl 240 Mg Caps Packsize 28 Accupro Tabs 5 Mg Packsize 28 Adizem Xl 300 Mg Caps Packsize 28 Accuretic Tabs Packsize 28 Adoport Caps 1 Mg Packsize 100 Acebutolol Caps 100 Mg Packsize 84 Adoport Caps 1 Mg Packsize 50 Acebutolol Caps 200 Mg Packsize 56 Adoport Caps 500 Micrograms Packsize 50 Acebutolol Tabs 400 Mg Packsize 28 Advagraf Caps 1 Mg Packsize 100 Aceclofenac Tabs 100 Mg Packsize 60 Advagraf Caps 1 Mg Packsize 50 Aceclofenac Tabs 100 Mg Packsize 60 Advagraf Caps 3 Mg Packsize 50 Aceclofenac Tabs 100 Mg Packsize 60 Advagraf Caps 5 Mg Packsize 50 Aceclofenac Tabs 100 Mg Packsize 60 Advagraf Caps 500 Micrograms Packsize 50 Acemetacin Caps 60 Mg Packsize 90 Agnus Castus Tabs 30 C Packsize 50 Acenocoumarol Tabs 1 Mg Packsize 100 Agomelatine Tabs 25 Mg Packsize 28 Acetazolamide Mr Caps 250 Mg Packsize 30 Airomir 100 Mcg/Dose 200 Dose Cfc Free Inhal Acetazolamide Tabs 250 Mg Packsize 112 Packsize 1 Acetazolamide Tabs 250 Mg Packsize 112 Airomir Autohaler 100 Mcg/Dose 200 Dose Cfc Free Aciclovir 200 Mg Tabs Packsize 25 Inhal Packsize 1 Aciclovir 200 Mg Dispersible Tabs Packsize 25 Aknemin Caps 100 Mg Packsize 28 Aciclovir 3 % Eye Oint Packsize 4.5 Aknemin Caps 50 Mg Packsize 56 Aciclovir 400 Mg Tabs Packsize 56 Aknemycin Plus Sol Packsize 25 Aciclovir 400 Mg Dispersible Tabs Packsize 56 Alateris Tabs 625 Mg Packsize 60 Aciclovir 5 % Cream Packsize 10 Alclometasone Dipropionate Cream .05 % Packsize Aciclovir 5 % Cream Packsize 2 50 Aciclovir 800 Mg Tabs Packsize 35 Alclometasone Dipropionate Oint .05 % Packsize 50 Aciclovir 800 Mg Dispersible Tabs Packsize 35 Aldactide 25 Tabs Packsize 100 Acipimox Caps 250 Mg Packsize 90 Aldactide 50 Tabs Packsize 100 Acitretin Caps 10 Mg Packsize 60 Aldactide 50 Tabs Packsize 28 Acitretin Caps 25 Mg Packsize 60 Aldactone Tabs 100 Mg Packsize 28 Acnamino Mr Caps 100 Mg Packsize 56 Aldactone Tabs 25 Mg Packsize 100 Aconite Tabs 30 C Packsize 84 Aldactone Tabs 50 Mg Packsize 100 Aconite Tabs 6 C Packsize 125 Aldara Cream Sach 5 % Packsize 12 Acriflex Cream .25 % Packsize 30 Aldomet Tabs 250 Mg Packsize 60 Acrivastine 8 Mg Caps Packsize 24 Aldomet Tabs 500 Mg Packsize 30 Acrivastine Caps 8 Mg Packsize 12 Alendronic Acid 10 Mg Tabs Packsize 28 Actikerall Sol Packsize 25 Alendronic Acid 70 Mg Once Weekly Tabs Packsize Actonel 35 Mg Once A Week Tabs Packsize 4 4 Actonel Tabs 30 Mg Packsize 28 Alendronic Acid Soln 70 Mg/100ml Packsize 4 Actonel Tabs 5 Mg Packsize 28 Alfacalcidol 1 Micrograms Caps Packsize 30 Actos 30mg Tabs Packsize 28 Alfacalcidol 250 Nanograms Caps Packsize 30 Actos 45 Mg Tabs Packsize 28 Alfacalcidol 500 Nanograms Caps Packsize 30 Adalat 10 Retard 10 Mg Tabs Packsize 56 Alfuzosin Hydrochloride 2.5 Mg Tabs Packsize 28 Adalat 5 Caps 5 Mg Packsize 90 Alfuzosin Hydrochloride Mr 10 Mg Tabs Packsize 30 Adalat Caps 10 Mg Packsize 90 Algesal 10 % Cream Packsize 50 Adalat La 20 Mg Tabs Packsize 28 Algesal Cream 10 % Packsize 100 Adalat La 30 Mg Tabs Packsize 28 Alimemazine Tartrate 10 Mg Tabs Packsize 28 Adalat La 60 Mg Tabs Packsize 28 Alimemazine Tartrate 7.5 Mg/5ml Syrup Packsize Adalat Retard 20 Mg Tabs Packsize 56 100 Adapalene 0.1 % Cream Packsize 45 Aliskiren Tabs 150 Mg Packsize 28 Adapalene 0.1 % Gel Packsize 45 Aliskiren Tabs 300 Mg Packsize 28 Adartrel Tabs 2 Mg Packsize 28 Alitretinoin Caps 10 Mg Packsize 30 Adartrel Tabs 250 Micrograms Packsize 12 Alitretinoin Caps 30 Mg Packsize 30 Adartrel Tabs 500 Micrograms Packsize 28 Allegron 10 Mg Tabs Packsize 100 Adcal 1.5 G Sf Contains Calcium 600mg Chewable Allegron 25 Mg Tabs Packsize 100 Tabs Packsize 100 Alli Caps 60 Mg Packsize 84 Adcal D3 Chewable Tabs Packsize 112 Allium Cepa Tabs 6 C Packsize 125 Adcal D3 Chewable Tabs Packsize 112 Allopurinol 100 Mg Tabs Packsize 28 Allopurinol 300 Mg Tabs Packsize 28 Amoxil Caps 250 Mg Packsize 21 Almogran Tabs 12.5 Mg Packsize 3 Amoxil Caps 500 Mg Packsize 21 Almogran Tabs 12.5 Mg Packsize 6 Amoxil Paediatric Susp 125 Mg/1.25ml Packsize 20 Almogran Tabs 12.5 Mg Packsize 9 Ampicillin Caps 250 Mg Packsize 28 Almond Oil Packsize 50 Ampicillin Caps 500 Mg Packsize 28 Almond Oil Packsize 500 Anacal Oint Packsize 30 Almotriptan 12.5 Mg Tabs Packsize 6 Anadin Liquifast Caps 200 Mg Packsize 16 Almotriptan 12.5 Mg Tabs Packsize 9 Anadin Liquifast Caps 200 Mg Packsize 32 Almotriptan Tabs 12.5 Mg Packsize 3 Anadin Liquifast Caps 200 Mg Packsize 8 Alomide .1 % Drops Eye Packsize 10 Anadin Liquifast Caps 400 Mg Packsize 10 Alphaderm Cream Packsize 100 Anadin Liquifast Caps 400 Mg Packsize 20 Alphaderm Cream Packsize 30 Anafranil Caps 10 Mg Packsize 84 Alphagan 0.2 % Ophthalmic Sol Packsize 5 Anafranil Caps 25 Mg Packsize 84 Alphosyl 2 In 1 Shampoo Packsize 125 Anafranil Caps 50 Mg Packsize 56 Alphosyl 2 In 1 Shampoo Packsize 250 Anafranil Sr Tabs 75 Mg Packsize 28 Alphosyl Hc Cream Packsize 100 Anagrelide Hydrochloride Caps 500 Micrograms Alucap Caps 475 Mg Packsize 120 Packsize 100 Aluminium Hydroxide Dried Caps 475 Mg Packsize Anastrozole 1 Mg Tabs Packsize 28 120 Anastrozole 1 Mg Tabs Packsize 28 Alventa Xl Caps 150 Mg Packsize 28 Anastrozole 1 Mg Tabs Packsize 28 Alventa Xl Caps 75 Mg Packsize 28 Anastrozole Tabs 1 Mg Packsize 28 Alverine Citrate 120 Mg Caps Packsize 60 Androcur Tabs 50 Mg Packsize 56 Alverine Citrate 60 Mg Caps Packsize 100 Angeliq Tabs Packsize 84 Alverine Citrate Caps 120 Mg Packsize 60 Angitil 120 Sr 120 Mg Caps Packsize 56 Alverine Citrate Caps 60 Mg Packsize 100 Angitil 180 Sr 180 Mg Caps Packsize 56 Amaryl Tabs 1 Mg Packsize 30 Angitil 90 Sr 90 Mg Caps Packsize 56 Amaryl Tabs 2 Mg Packsize 30 Angitil Xl 240 Mg Caps Packsize 28 Amaryl Tabs 3 Mg Packsize 30 Angitil Xl 300 Mg Caps Packsize 28 Amaryl Tabs 4 Mg Packsize 30 Anhydrol Forte 20 % Appl Packsize 60 Amfebutamone Hydrochloride Mr Tabs 150 Mg Anodesyn Oint Packsize 25 Packsize 60 Anthelios Melt-In Cream Packsize 50 Amias 16mg Tabs Packsize 28 Antisan Bite And Sting Cream 2 % Packsize 20 Amias 2 Mg Tabs Packsize 7 Anugesic Hc Cream Packsize 30 Amias 4mg Tabs Packsize 28 Anugesic Hc Supps Packsize 12 Amias 8 Mg Tabs Packsize 28 Anusol Cream Packsize 23 Amiloride 5 Mg Tabs Packsize 28 Anusol Cream Packsize 43 Amiloride 5 Mg Tabs Packsize 28 Anusol Oint Packsize 25 Amiloride Soln 5 Mg/5ml Packsize 150 Anusol Supps Packsize 12 Aminophylline Mr Tabs 350 Mg Packsize 56 Anusol Supps Packsize 24 Amiodarone Hydrochloride 100 Mg Tabs Packsize Anusol Hc Oint Packsize 30 28 Anusol Hc Supps Packsize 12 Amiodarone Hydrochloride 200 Mg Tabs Packsize Anusol Plus Hc Oint Packsize 15 28 Apercap Caps .2 Ml Packsize 84 Amisulpride 100 Mg Tabs Packsize 60 Apidra Solostar 100 Units/Ml Prefilled Disposable Amisulpride 200 Mg Tabs Packsize 60 Pen Inj Packsize 5 Amisulpride 400 Mg Tabs Packsize 60 Apis Mel Tabs 6 C Packsize 125 Amisulpride 50 Mg Tabs Packsize 60 Apresoline Tabs 25 Mg Packsize 84 Amisulpride Soln 100 Mg/Ml Packsize 60 Aprinox Tabs 2.5 Mg Packsize 500 Amitriptyline Hydrochloride 10 Mg Tabs Packsize 28 Aprinox Tabs 5 Mg Packsize 500 Amitriptyline Hydrochloride 25 Mg Tabs Packsize 28 Aprovel 150mg Tabs Packsize 28 Amitriptyline Hydrochloride 50 Mg Tabs Packsize 28 Aprovel 300mg Tabs Packsize 28 Amitriptyline Soln 25 Mg/5ml Packsize 150 Aprovel 75 Mg Tabs Packsize 28 Amitriptyline Soln 25 Mg/5ml Packsize 150 Aquadrate 10 % Cream Packsize 100 Amitriptyline Soln 25 Mg/5ml Packsize 150 Aqueous Cream Packsize 100 Amitriptyline Soln 50 Mg/5ml Packsize 150 Aqueous Cream Packsize 500 Amitriptyline Soln 50 Mg/5ml Packsize 150 Arava 10 Mg Tabs Packsize 30 Amitriptyline Soln 50 Mg/5ml Packsize 150 Arava 20 Mg Tabs Packsize 30 Amlodipine 10 Mg Tabs Packsize 28 Arcoxia Tabs 120 Mg Packsize 28 Amlodipine 5 Mg Tabs Packsize 28 Arcoxia Tabs 120 Mg Packsize 7 Amlostin Tabs 10 Mg Packsize 28 Argent Nit Tabs 30 C Packsize 125 Amlostin Tabs 5 Mg Packsize 28 Argent Nit Tabs 30 C Packsize 125 Amorolfine 5 % Nail Lacquer Sol Packsize 3 Argent Nit Tabs 6 C Packsize 125 Amorolfine 5 % Nail Lacquer Sol Packsize 5 Aricept Evess Tabs 10 Mg Packsize 28 Amoxicillin 125 Mg/1.25ml Paediatric Susp Packsize Aricept Evess Tabs 5 Mg Packsize 28 20 Arimidex 1 Mg Tabs Packsize 28 Amoxicillin 125 Mg/5ml Susp Packsize 100 Aripiprazole 10 Mg Tabs Packsize 28 Amoxicillin 125 Mg/5ml Sf Susp Packsize 100 Aripiprazole 15 Mg Tabs Packsize 28 Amoxicillin 125 Mg/5ml Sf Syrup Packsize 100 Aripiprazole
Load more

Recommended publications
  • Core Topics in Mechanical Ventilation Edited by Iain Mackenzie Index More Information
    Cambridge University Press 978-0-521-86781-8 - Core Topics in Mechanical Ventilation Edited by Iain Mackenzie Index More information Index Abdominal distension in lung elastance oxygen toxicity 270 incidence data 240 345, 346 patient assessment 118, 115–119, 120 laryngeal injuries 248, 247–248 Abdominal paradox 27 recruitment manoeuvres 118–119, left ventricular performance 273 N-Acetylcysteine 79–80, 81, 357, 358 131, 219 lorazepam 165 Acinetobacter baumanii, SDD for 260 trials (See ARDS net trials) lung injury, ventilator-associated (See Acute hypoxaemic respiratory failure ventilation management Lung injury, defined 115 HFOV 127–131, 305–306 ventilator-associated) Acute lung injury (ALI) IRV 125–126 maxillary sinusitis/middle ear blast injuries 212 liquid 228 effusions 246–247 hypoxaemia, PEEP management of modes 215–216 midazolam 165 124–125 overview 214 nasopharyngeal airways 243–245, infants/children 300–301 principles 214–215, 216 246–247 liquid ventilation 228 Acute respiratory failure (ARF) nasotracheal intubation 315 patient assessment 118, 115–119, clinical presentation 29 neurological function 277, 276–277, 120, 197 mechanisms of 24 278, 280 recruitment manoeuvres 131, 219 NIV 43, 49–50 (See also Non-invasive NMBAs 171, 176–177, 276–280 ventilation management ventilation (NIV)) NSAIDs 181 HFV 149–150 overview 24, 22–24, 25, 142 opioid agonists 180 IRV 125–126 Adaptive support ventilation® 113, 361 opioids 276–280 modes 215–216 Adrenaline 81 overview 21, 239, 241 overview 214 Adrenergic receptor antagonists 349, oxygen toxicity
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew Et Al
    US009314465B2 (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew et al. (45) Date of Patent: *Apr. 19, 2016 (54) DRUG COMBINATIONS AND USES IN 2008.0003280 A1 1/2008 Levine et al. ................. 424/456 TREATING A COUGHING CONDITION 2008/O176955 A1 7/2008 Hecket al. 2008, 0220078 A1 9, 2008 Morton et al. (71) Applicant: Infirst Healthcare Limited 2009, O136427 A1 5/2009 Croft et al. 2009, O220594 A1 9, 2009 Field (72) Inventors: John Brew, London (GB); Robin Mark 2012/O128738 A1 5, 2012 Brew et al. Bannister, London (GB) 2012fO252824 A1 10/2012 Brew et al. (73) Assignee: Infirst Healthcare Limited, London FOREIGN PATENT DOCUMENTS (GB) CN 1593451 3, 2005 CN 101024.014 A 8, 2007 (*) Notice: Subject to any disclaimer, the term of this CN 101112383 B 5, 2010 patent is extended or adjusted under 35 DE 4420708 A1 12, 1995 U.S.C. 154(b) by 0 days. EP 2050435 B1 4/2009 GB 2114001 A 8, 1983 This patent is Subject to a terminal dis GB 2284761 A 6, 1995 claimer. GB 2424.185 B 9, 2006 GB 2442828 A 4/2008 JP 62-249924 A 10, 1987 (21) Appl. No.: 14/287,014 JP H1O-316568 A 12/1998 JP 2001-518928 A 10, 2001 (22) Filed: May 24, 2014 JP 200219.3839. A T 2002 JP 2003-012514 A 1, 2003 (65) Prior Publication Data JP 20030552.58 A 2, 2003 JP 2003128549 A 5, 2003 US 2014/O256750 A1 Sep. 11, 2014 JP 2003-321357 A 11, 2003 JP 2005-516917 A 6, 2005 JP 2008O31146 A 2, 2008 Related U.S.
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug
    USOO544607OA United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug. 29, 1995 54 COMPOST ONS AND METHODS FOR 4,659,714 4/1987 Watt-Smith ......................... 514/260 TOPCAL ADMNSTRATION OF 4,675,009 6/1987 Hymes .......... ... 604/304 PHARMACEUTICALLY ACTIVE AGENTS 4,695,465 9/1987 Kigasawa .............................. 424/19 4,748,022 5/1988 Busciglio. ... 424/195 75 Inventor: Juan A. Mantelle, Miami, Fla. 4,765,983 8/1988 Takayanagi. ... 424/434 4,789,667 12/1988 Makino ............ ... 514/16 73) Assignee: Nover Pharmaceuticals, Inc., Miami, 4,867,970 9/1989 Newsham et al. ... 424/435 Fla. 4,888,354 12/1989 Chang .............. ... 514/424 4,894,232 1/1990 Reul ............. ... 424/439 * Notice: The portion of the term of this patent 4,900,552 2/1990 Sanvordeker .... ... 424/422 subsequent to Aug. 10, 2010 has been 4,900,554 2/1990 Yanagibashi. ... 424/448 disclaimed. 4,937,078 6/1990 Mezei........... ... 424/450 Appl. No.: 112,330 4,940,587 7/1990 Jenkins ..... ... 424/480 21 4,981,875 l/1991 Leusner ... ... 514/774 22 Filed: Aug. 27, 1993 5,023,082 6/1991 Friedman . ... 424/426 5,234,957 8/1993 Mantelle ........................... 514/772.6 Related U.S. Application Data FOREIGN PATENT DOCUMENTS 63 Continuation-in-part of PCT/US92/01730, Feb. 27, 0002425 6/1979 European Pat. Off. 1992, which is a continuation-in-part of Ser. No. 0139127 5/1985 European Pat. Off. 813,196, Dec. 23, 1991, Pat. No. 5,234,957, which is a 0159168 10/1985 European Pat.
    [Show full text]
  • Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine 2013
    Nucleosides, Nucleotides, Heterocyclic Compounds, Pyridine, Pyrimidine, Azaindole, Quinoline, Thiazole, Isatin, Phenanthrene, Thiophene We declare that some of the listed products might be protected by valid patents. They are only for scientific research and development purpose. They are not offered for sales in countries where the sales of such products constitutes patents infringement. The liability for patents checking and patents infringement is exclusive at buyers risk! I2CNS LLC CANNOT BE HELD LIABLE FOR ANY VIOLATIONS OF PATENT RIGHTS CAUSED BY CUSTOMERS. CAS No. Product Name and Description 26988-72-7 1-METHYL-DL-TRYPTOPHAN 68886-07-7 2-Fluoro-4-hydroxyphenylaceticacid 72607-53-5 N-(3-AMINOPROPYL)METHACRYLAMIDE 171049-41-5 7-AMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLICACIDTERT- BUTYLESTER 885280-38-6 (3-OXO-CYCLOHEXYL)-CARBAMICACIDTERT-BUTYLESTER 186826-86-8 MOXIFLOXACIN HCL 102735-53-5 L-CYCLOPROPYLALANINE 145100-50-1 2-[N,N-BIS(TRIFLUOROMETHYLSULFONYL)AMINO]PYRIDINE 143491-57-0 Emtricitabine 39809-25-1 2-Amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one 147127-20-6 Tenofovir 716-39-2 2,3-NAPHTHALENEDICARBOXYLICANHYDRIDE 4333-62-4 1,3-DIMETHYLIMIDAZOLIUMIODIDE 108-45-2 m-Phenylenediamine 1961-72-4 R-(3)-HYDROXYMYRISTICACID 131-48-6 N-Acetylneuraminicacid 88196-70-7 (R)-1-(3-Methoxyphenyl)ethylamine 680-31-9 Hexamethylphosphoramide 486-66-8 Daidzein 872-50-4 1-Methyl-2-pyrrolidinone 425378-68-3 2-FLUORO-5-NITROPHENYLBORONICACIDPINACOLESTER 115651-29-1 5-ACETYL-2-AMINO-4-HYDROXYBENZOICACID 115269-99-3 N,N-BIS-BOC-N-ALLYLAMINE
    [Show full text]
  • Pharmaceutical Compoundingand Dispensing, Second
    Pharmaceutical Compounding and Dispensing Pharmaceutical Compounding and Dispensing SECOND EDITION John F Marriott BSc, PhD, MRPharmS, FHEA Professor of Clinical Pharmacy Aston University School of Pharmacy, UK Keith A Wilson BSc, PhD, FRPharmS Head of School Aston University School of Pharmacy, UK Christopher A Langley BSc, PhD, MRPharmS, MRSC, FHEA Senior Lecturer in Pharmacy Practice Aston University School of Pharmacy, UK Dawn Belcher BPharm, MRPharmS, FHEA Teaching Fellow, Pharmacy Practice Aston University School of Pharmacy, UK Published by the Pharmaceutical Press 1 Lambeth High Street, London SE1 7JN, UK 1559 St Paul Avenue, Gurnee, IL 60031, USA Ó Pharmaceutical Press 2010 is a trade mark of Pharmaceutical Press Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society of Great Britain First edition published 2006 Second edition published 2010 Typeset by Thomson Digital, Noida, India Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 912 5 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of the information contained in this book and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The right of John F Marriott, Keith A Wilson, Christopher A Langley and Dawn Belcher to be identified as the author of this work has been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • European Patent Office
    Europäisches Patentamt *EP001021204B1* (19) European Patent Office Office européen des brevets (11) EP 1 021 204 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: A61K 47/32, A61L 25/00 of the grant of the patent: 28.12.2005 Bulletin 2005/52 (86) International application number: PCT/US1998/020091 (21) Application number: 98949505.6 (87) International publication number: (22) Date of filing: 25.09.1998 WO 1999/015210 (01.04.1999 Gazette 1999/13) (54) BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS BIOLOGISCHE KLEBER UND VERFAHREN ZUR TOPISCHEN VERABREICHUNG VON WIRKSTOFFEN COMPOSITIONS BIOADHESIVES ET METHODES D’ADMINISTRATION LOCALE D’AGENTS ACTIFS (84) Designated Contracting States: • HOUZE, David AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Miami, FL 33186 (US) MC NL PT SE • KANIOS, David Miami, FL 33196 (US) (30) Priority: 26.09.1997 US 61155 P (74) Representative: Isenbruck, Günter (43) Date of publication of application: Isenbruck, Bösl, Hörschler, Wichmann, Huhn 26.07.2000 Bulletin 2000/30 Patentanwälte Theodor-Heuss-Anlage 12 (73) Proprietor: NOVEN PHARMACEUTICALS, INC. 68165 Mannheim (DE) Miami, FL 33186 (US) (56) References cited: (72) Inventors: FR-A- 2 532 546 GB-A- 1 050 070 • MANTELLE, Juan GB-A- 2 046 773 US-A- 4 593 053 Miami, FL 33176 (US) US-A- 5 656 286 Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted.
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • Electronic Supplementary Material
    Supplementary material Thorax Electronic Supplementary Material Contents: MEDLINE search strategy: ........................................................................................................ 1 Number of search results according to data source: .................................................................. 4 Inclusion/Exclusion criteria of eligible trials: ............................................................................ 5 List of excluded studies after full text review: ......................................................................... 14 Reporting of adverse events and development of other pathologies: ...................................... 19 Deviations between this review and protocol: ......................................................................... 20 Funnel Plots: ............................................................................................................................ 20 Explanation for observed Risk of Bias differences for included trials between this review and Tarrant 2019 review: ................................................................................................................ 24 MEDLINE search strategy: Search was adapted appropriately for other databases. Condition: 1. Acute hypoxic respiratory failure 2. Acute hypoxemic respiratory failure 3. Acute hypoxaemic respiratory failure 4. Acute hypercapnic respiratory failure 5. AHRF 6. Respiratory Distress Syndrome, Adult/ 7. Acute respiratory failure 8. ARF 9. Severe hypoxic respiratory failure 10. Severe
    [Show full text]
  • Wo 2009/015286 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 29 January 2009 (29.01.2009) WO 2009/015286 A2 (51) International Patent Classification: Not classified AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY,BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, (21) International Application Number: EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, PCT/US2008/071055 IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY,MA, MD, ME, MG, MK, MN, MW, (22) International Filing Date: 24 July 2008 (24.07.2008) MX, MY,MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TJ, (25) Filing Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 60/961,872 24 July 2007 (24.07.2007) US GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), (71) Applicant (for all designated States except US): NEXBIO, European (AT,BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, INC. [US/US]; 10665 Sorrento Valley Road, San Diego, California 92121 (US). FR, GB, GR, HR, HU, IE, IS, IT, LT,LU, LV,MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, (72) Inventors; and CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
    [Show full text]